Morphosys Ag (MOR.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 59,078 | 63,800 | 53,165 | 62,318 | 81,667 |
| Cost of Goods | 14,555 | 15,100 | 7,701 | 20,985 | 15,420 |
| Gross Profit | 44,424 | 48,700 | 45,464 | 41,333 | 66,147 |
| Operating Expenses | 125,780 | 98,100 | 96,008 | 110,834 | 134,558 |
| Operating Income | -81,356 | -49,400 | -50,544 | -69,501 | -68,411 |
| Interest Expense | 8,658 | 67,100 | 28,321 | 28,261 | -298,880 |
| Other Income | 136,492 | -2,600 | 6,710 | 53,331 | 271,552 |
| Pre-tax Income | 46,478 | -119,100 | -72,155 | -44,432 | 502,021 |
| Income Tax | -1,689 | 500 | 0 | 0 | 172,679 |
| Net Income Continuous | 48,266 | -119,600 | -73,967 | -44,432 | 329,342 |
| Net Income | $48,266 | $-119,600 | $-73,967 | $-44,432 | $329,442 |
| EPS Basic Total Ops | 1.44 | -3.50 | -2.16 | -1.30 | 9.65 |
| EPS Basic Continuous Ops | 1.44 | -3.50 | -2.16 | -1.30 | 9.65 |
| EPS Diluted Total Ops | 1.44 | -3.50 | -2.16 | -1.30 | 9.65 |
| EPS Diluted Continuous Ops | 1.44 | -3.50 | -2.16 | -1.30 | 9.65 |
| EBITDA(a) | $55,136 | $-52,000 | $-40,854 | $-13,407 | $203,141 |